IBM Watson is taking the fight to cancer as more hospitals and medical research firms around the world use the resource in their ongoing war to treat the dreaded disease.
The Jeopardy champion has been consistently improving when it comes to designing treatment plans for cancer victims, Engadget reported.
New data presented to the American Society of Clinical Oncology showed suggested treatment plans from Watson were often exactly what physicians would recommend.
Recent research from India showed Watson’s suggested treatments for colon cancer matched physicians recommendations 81 percent of the time, 93 percent of the time for rectal cancer, and 96 percent of the time for lung cancer.
A study from Thailand showed comparable rates of agreements for lung, breast, colorectal and gastric cancer treatments.
Healthcare researchers are increasingly using Watson for Oncology, a cognitive computing system trained by doctors from Memorial Sloan Kettering. The system takes a patient’s medical history, extracts information from the records, and is able to design a personalized treatment plan.
Watson for Oncology just made its debut in Australia, with Queensland-based Icon Group signing up with IBM and helping oncologists across the country, the Australian Business Review reported.
Icon Group will implement an “augmented intelligence platform” to help clinicians stay on top of ever increasing amounts of cancer research.
“Traditionally they rely on a series of conferences and journals and have to soak up every bit of the new research, but Watson gives them easier access to this information,” said Cathie Reid, one of Icon’s co-founders.
The Georgia Cancer Center is also making use of IBM Watson to quickly assess genetic markers in tumors, according to the Augusta Chronicle.
With so many taking advantage of IBM Watson as a powerful resource, the system continues to prove itself as a desired ally in the fight against cancer.